Cookies on this website

We use cookies to improve your experience of our website. You can find out more or opt-out from some cookies.

Skip to content

BETA This is a new service – your feedback will help us to improve it.

Healthcare Improvement Scotland
  • Clinical guidance for professionals
  • Improving care
  • Inspections, reviews and regulation
  • Work with us
  • News and publications
    1. Home
    2. Process guidance
    3. NCMAG advice
    4. NCMAG121 Nivolumab in combination with ipilimumab Advice Document

    Back to   Home

    NCMAG121 Nivolumab in combination with ipilimumab Advice Document

    Posted on: 24 April 2025


    Document Type

    NCMAG advice

    Process guidance

    Summary

    Nivolumab in combination with ipilimumab for the neoadjuvant treatment of
    resectable stage III melanoma

    Decision: Supported


    Documents

    NCMAG121 Nivolumab in combination with ipilimumab Advice Document : April 2025

    PDF, 342 KB

    Posted in NCMAG advice, Process guidance

    • Facebook
    • YouTube
    • LinkedIn
    • X
    • Our blog
    • Our podcasts
    • About us
    • Contact us

    Policy links

    • How we use cookies
    • Our privacy policy
    • Accessibility statement
    • Copyright information
    • Complaints and feedback

    © Copyright, Healthcare Improvement Scotland 2025